Educational Qualification:

Degree	Year	Name Of College & University	Registration number with date of registration	Name of state Medical council
MBBS	1984	GMC NAGPUR ,NAGPUR UNIVERSITY	57022 21/10/86	NMC
MD (Internal Medicine)	1990	GMC NAGPUR ,NAGPUR UNIVERSITY	8967 16/11/92	NMC
DTCD	1987	GMC NAGPUR ,NAGPUR UNIVERSITY	8967 16/11/92	NMC

3) Professor since: year  12/07/2010

4) No. Of Publications: 

	Publications	Number
a	National	40
b	International	20
c	Book- Chapter	9
d	Journal Editor	2

5) Conference/CME hosted by department in 2025-26

Sr No.	Conference/ CME hosted by department in last 3 year		Date/Year
1	World TB Day Quiz Program		22 March 2025
2	World TB Day SKIT + Poster Competition		24 March 2025
3	World Asthma day quiz		31 May 2025
4	World NO tobacco day		31 May 2025
5	TB sensitization program		4 October 2025
6	World TB Day Quiz Program	Intracollegiate interdepartmental TB quiz organized by the department	22 March 2025
7	STOP-TB ETTi Webinar: e-NEETI Sensitization of Health Care Workers in Basics of Airborne Infection Prevention and Control	World TB Day awareness webinar; Faculty talk by Dr. Gyanshankar Mishra	21 March 2025
8	Online TB Guardianship Webinar on Drug-Resistant TB	Dr. Radha Munje and Dr. Gyanshankar Mishra participated as speakers	28 March 2025
9	TB Sensitization Program	TB sensitization academic program organized by the department	4 October 2025
10	World Asthma Day Quiz	Academic awareness activity conducted by department	31 May 2025
11	ICS Talent Search (West Zone)	Organized under the aegis of Indian Chest Society	12 October 2025
12	Ultrasonography for Pulmonologists – Hands-on Lung Ultrasound Workshop	Conducted by Department of Respiratory Medicine, IGGMC Nagpur in collaboration with Vidarbha Chest Association	2 November 2025
13	TB MUKT BHARAT ABHIYAAN	Sensitisation/Training for NTEP staff on TPT for Household contacts of Drug Resistant Tuberculosis	22 may 2026

Extramural Grants

S.No	Grants	Project Files	Duration	Role (PI or Co-PI/Coordinator or Co-Investigator)	Funding Agency Name
1	–	HAaLt TB In Nagpur (Household Active and Latent Tuberculosis Intervention in Nagpur)	Completed	PI: Dr Radha Munje CoPI: Dr Gyanshankar Mishra	Central TB Division (CTD) & National TB Elimination Program (NTEP) Collaborating Institutions: • Central Tuberculosis Division (CTD),MoHFW, GOI • Indira Gandhi Government Medical College (IGGMC),Maharashtra • U.S. Centers for Disease Control and Prevention (CDC) •National TB Elimination Program( NTEP) Nagpur Rural and Corporation • SHARE India • Public Health Foundation of India (PHFI)
2	–	Multi-centric prospective cohort study of TB recurrence free cure among microbiologically confirmed new pulmonary tuberculosis patients treated under NTEP with the 4-month moxifloxacin containing daily regimen	Completed	PI: Dr Radha Munje CoI: Dr Gyanshankar Mishra	ITRC, ICMR Collaborating Institutions: ICMR-NIRT, Chennai
3	–	Development and validation of artificial intelligence tool for screening and detection of pulmonary TB and other lung diseases using chest x-rays.	Ongoing	PI: Dr Radha Munje CoI: Dr Gyanshankar Mishra	ICMR

6.B. Investigator-Initiated Academic Research

The Department of Respiratory Medicine, Indira Gandhi Government Medical College, Nagpur, actively undertakes investigator-initiated research addressing critical challenges in tuberculosis care, spanning prescription practices, treatment safety, and programmatic implementation.

These studies are conducted independently without external funding, reflecting a strong academic commitment to generating clinically relevant and policy-oriented evidence. Collectively, they provide real-world insights aimed at improving the quality of tuberculosis management in India.

1. PRAMAN India Study

(Prescription Review and Meta-analysis of Anti-tuberculosis treatment in Non-programmatic settings in India)

The PRAMAN India Study is a first-of-its-kind systematic review and meta-analysis evaluating anti-tuberculosis prescription practices in non-programmatic settings across India over three decades (1990–2024). The study synthesises evidence from multiple regions to assess the prevalence, patterns, and determinants of inappropriate tuberculosis prescriptions.

It provides nationally representative evidence on deviations from standard treatment guidelines, highlights variations across provider types and regions, and identifies critical gaps in treatment practices. The findings offer important insights for strengthening tuberculosis care, improving prescription quality, and informing policy and programmatic interventions.

The study was presented at the Asia Pacific Region Conference of the International Union Against Tuberculosis and Lung Disease (APRC 2026), Bangkok, Thailand (5 February 2026) by Dr. Gyanshankar Mishra, reflecting its relevance to regional and international tuberculosis discourse.
Explore the PRAMAN India Study (full details, methodology, and insights): https://sites.google.com/smpalmaarifaluelhok.my.id/pramanindiastudy/

2. Linezolid Safety Study in Drug-Resistant Tuberculosis

Adverse Drug Reactions due to Linezolid in the Programmatic Management of Drug-Resistant Tuberculosis in India: A Retrospective Multicenter Study

This investigator-initiated, multicenter study evaluated adverse drug reactions associated with linezolid use in patients with multidrug-resistant and rifampicin-resistant tuberculosis under programmatic conditions in India. Conducted across multiple tuberculosis units, the study provides real-world evidence on the safety profile of linezolid in bedaquiline-based regimens.

A substantial proportion of patients experienced adverse drug reactions, particularly peripheral neuropathy, often requiring dose modification or discontinuation. The study highlights the importance of early detection, active drug safety monitoring (aDSM), and rational use of linezolid in programmatic settings.

Reference:
Mishra G, Alffenaar J-W, Munje R, Khateeb S. Adverse drug reactions due to linezolid in the programmatic management of drug-resistant tuberculosis in India: A retrospective multicenter study. Indian Journal of Tuberculosis. 2024;71:S101–9. https://doi.org/10.1016/J.IJTB.2023.04.006

3. INH Mono-Resistant Tuberculosis Study

Treatment Outcomes of Isoniazid Mono-Resistant Tuberculosis under Programmatic Management in India

This investigator-initiated study evaluated treatment outcomes of isoniazid (INH) mono-resistant tuberculosis using a standardized regimen under programmatic management conditions in India. The study assessed real-world effectiveness of treatment strategies in routine healthcare settings.

The findings demonstrated favourable treatment outcomes, supporting the effectiveness of standardized regimens for INH mono-resistant tuberculosis within national programmes. The study also underscores the importance of appropriate drug resistance testing and systematic monitoring in optimizing treatment outcomes. This work contributes to strengthening evidence-based management of drug-resistant tuberculosis at the programmatic level.

The study was presented at the World Conference on Lung Health 2023 (The Union), Paris, France by Dr. Radha Munje.

Reference:
Munje R, Mishra G, Agrawal K, Khateeb S, Jichkar S, Gour S. Outcome of isoniazid-monoresistant TB with a new regimen under programmatic management of drug-resistant TB in India. The International Journal of Tuberculosis and Lung Disease. 2023;27(Suppl 1):S105.

Together, these investigator-initiated studies span the continuum of tuberculosis care—from prescription practices and programmatic implementation to treatment safety and clinical outcomes—providing a comprehensive evidence base to support improvements in tuberculosis management and policy in India.

6 . C. Community Projects

Active Case Finding of Tuberculosis in Nagpur City: A Multidisciplinary Collaborative Project (NIIDAN TB Project)
Institution: Indira Gandhi Government Medical College and Hospital (IGGMCH), Nagpur
Period: 23 July – 31 December 2025

The Department of Respiratory Medicine actively participated in the NIIDAN TB Project, a large-scale, multidisciplinary initiative aimed at early detection and control of tuberculosis in Nagpur. A total of 25,283 individuals were screened through verbal assessment, of whom 10,689 were identified as presumptive TB cases. Among these, 7,624 individuals underwent AI-assisted chest X-ray screening, yielding 1,238 AI-suspected cases. Subsequently, 1,376 sputum samples were collected, with 1,195 tested by RT-PCR, resulting in the detection of 53 confirmed TB cases. Contact tracing identified 169 household contacts, of whom 139 underwent Cy-TB screening, leading to the identification of 7 additional Cy-TB positive cases.

The Department played a key leadership and operational role in this project. Dr. Radha Munje served as Chairman, Dr. Gyanshankar Mishra was a Core Working Group member, and Dr. Kapil Mate and Dr. Sadaf Khatib were part of the College-Level Supervisory Committee. The project was executed in collaboration with multiple departments, including Microbiology, Radiology, and Preventive and Social Medicine (PSM), highlighting a strong multidisciplinary approach to TB elimination.

Extracurricular Activities

The Department of Respiratory Medicine actively promotes student engagement and awareness through various extracurricular activities, particularly in observance of World TB Day and other academic forums:

• A painting competition for MBBS and postgraduate students was आयोजित on 24 March 2023 to promote TB awareness.
• Skit performances by MBBS students focusing on TB awareness were organized on World TB Day in 2023, 2024, and 2025, encouraging creative health communication.
• An interdepartmental quiz competition was conducted on 24 March 2025 to enhance knowledge and participation in TB-related topics.
• Under the aegis of the Indian Chest Society (ICS), the ICS Talent Search (West Zone) was successfully organized on 12 October 2025.
• A hands-on workshop titled “Ultrasonography for Pulmonologists” (Lung Ultrasound Workshop) was conducted in collaboration with the Vidarbha Chest Association on 2 November 2025.

Public Health Outreach & Awareness Activities

The department is actively involved in public health advocacy and awareness initiatives to promote early diagnosis, treatment adherence, and community participation in tuberculosis elimination efforts.

• Gyanshankar Mishra contributed an awareness article titled “Do not let side effects stop your TB treatment” published in The Times of India (Nagpur Edition) on 24 March 2023 (World TB Day). The article highlighted the importance of continuing TB treatment despite adverse drug reactions, emphasizing patient counselling, early recognition of side effects, and adherence to therapy as key components of successful outcomes.

PG Dissertation Topics

S.No.	Year of Admission	Name of PG Student	PG Guide	Dissertation Topic
1	2014	DR PUNIT JHAWAR	DR RADHA MUNJE	EVALUATION OF CARDIAC INVOLVEMENT IN PATIENT OF INTERSTITIAL LUNG DISEASES
2	2014	DR VIJAY WALKE	DR SANJAY GOUR	CLINICO RADIOLOGICAL PROFILE OF HAEMOPTYSIS
3	2015	DR VANDANA P B	DR RADHA MUNJE	SPIROMETRIC EVALUATION OF TREATED CASES OF SPUTUM POSITIVE PULMONARY  TUBERCULOSIS
4	2015	DR NILESH SONAWARE	DR SANJAY GOUR	SPIROMETRIC EVALUATION OF CASES OF ALLERGIC RHINITIS
5	2016	DR NINU P BABU	DR RADHA MUNJE	UTILITY OF BRONCHOSCOPY IN IN CLINICAL AND RADIOLOGICAL SUSPECTS OF PULMONARY TUBER CULOSIS
6	2016	DR PRADIP JULA	DR SANJAY GOUR	SPIROMETRIC EVALUATION OF PATIENTS OF SICKLE CELL DISEASE
7	2017	DR MADHAV DAWKORE	DR SANJAY GOUR	UTILITY OF NIV IN COPD WITH TYPE 2 RESPIRATORY FAILURE IN TERTIARY CARE HOSPITAL
8	2017	DR AMOL RAMTEKE	DR RADHA MUNJE	STUDY OF POLYSOMNOGRAPHY IN PATIENTS OF METABOLIC SYNDROME
9	2017	DR RAHUL KUMAR MITTAL	DR RADHA MUNJE	DIAGNOSTIC YIELD OF VARIOUS BRONCHOSCOPIC PROCEDURES IN SUSPECTED CASES OF LUNG CANCER
10	2017	DR GOVINDA CHANDRAKER	DR RADHA MUNJE	DIFFUSING LUNG CAPACITY OF CARBON MONOXIDE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
11	2018	DR VIRENDRA KADAM	DR SANJAY GOUR	DIAGNOSTIC YIELD OF CLOSED PLEURAL BIOPSY IN EXUDATIVE PLEURAL EFFUSION
12	2018	DR ASHA SUSAN VARGHESE	DR RADHA MUNJE	TREATMENT OUTCOME OF PERIPHERAL TUBERCULAR LYMPHADENITIS WITH DAILY FIXED DOSE COMBINATION REGIMEN UNDER REVISED NATIONAL TUBERCULOSIS CONTROL PROGRAMME
13	2018	DR DIVYA JAYARAJAN	DR RADHA MUNJE	ROLE OF INTRAPLEURAL STREPTOKINASE IN COMPLICATED PLEURAL EFFUSION
14	2018	DR KAPIL MATE	DR GYANSHANKAR MISHRA	ADVERSE DRUG REACTIONS DUE TO DAILY FIXED DOSE COMBINATION FIRST LINE ANTI TUBERCULOSIS DRUGS
15	2019	Dr Ashish Kendre	Dr Gyanshankar Mishra	TO STUDY DLCO IN PATIENTS OF ACOS
16	2019	Dr Dhaval Bhadra	DR RADHA MUNJE	SLEEP RELATED DISORDERS IN PATIENTS OF COPD
17	2019	Dr Dinesh Suryavanshi	DR SANJAY GOUR	HAEMATOLOGICAL AND BIOCHEMICAL PARAMETERS IN TUBERCULOSIS
18	2019	Dr Neha Pachbai	DR RADHA MUNJE	OUTCOME OF TUBERCULOSIS PREGNANT FEMALE PATIENTS
19.	2020	Dr Anish R	DR RADHA MUNJE	STUDY ON INCIDENCE OF PULMONARY EMBOLISM IN PATIENTS OF COPD EXACERBATION
20.	2020	Dr. Kriti Agarwal	DR RADHA MUNJE	TO STUDY THE PREVALANCE OF METABOLIC SYNDROME IN PATIENTS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
21.	2020	Dr. Anjali Kamath	DR GYANSHANKAR MISHRA	STUDY OF DIFFUSING CAPACITY OF THE LUNGS FOR CARBON MONOXIDE(DLCO) IN TREATED CASES OF MICROBIOLOGICALLY CONFIRMED PULMONARY TUBERCULOSIS
22.	2020	Dr. DATTATRAY JUNNARKAR	DR.SANJAY GOUR	TO STUDY THE DIAGNOSTIC YIELD OF GASTRIC LAVAGE FOR DIAGNOSIS OF PULMONARY TUBERCULOSIS IN PATIENTS WHO ARE SPUTUM NEGATIVE
23	2022	DR.MOHD AATEER SHAIKH	DR.SANJAY GOUR	CLINICORADIOLOGICAL PROFILE OF INTERSTITIAL LUNG DISEASES IN TERTIARY CARE HOSPITAL –A CROSS SECTIONAL STUDY
24	2022	DR.NIRAJKUMAR DHAKARE	DR.GYANSHANKAR MISHRA	ADVERSE DRUG REACTIONS TO ANTI-TUBERCULOSIS DRUGS IN DRUG RESISTANT TB PATIENTS: AN AMBISPECTIVE COHORT STUDY
25	2022	Dr. DHRUVI RATHOD	DR.RADHA MUNJE	STUDY OF POSTOPERATIVE PULMONARY COMPLICATIONS IN HOSPITALISED CASES AT TERTIARY CARE HOSPITAL: AN OBSERVATIONAL STUDY
26	2022	DR.TWINKAL MAGAR	DR.RADHA MUNJE	CLINICO RADIOLOGICAL AND SPIROMETRIC EVALUATION OF COPD IN SMOKERS AND NON SMOKERS: AN OBSERVATIONAL (CROSS SECTIONAL STUDY)
27	2023	DR. PAYAL GAWAI	DR.RADHA MUNJE	CLINICAL, RADIOLOGICAL AND MICROBIOLOGICAL PROFILE OF PATIENTS WITH BRONCHIECTASIS IN A TERTIARY CARE HOSPITAL
28	2023	DR. ADITI SINGH	DR.SANJAY GOUR	SPIROMETRIC EVALUATION OF PATIENTS WITH METABOLIC SYNDROME A CROSS SECTIONAL STUDY
29	2023	DR. DIVYA WANKHEDE	DR.RADHA MUNJE	TUDY THE OUTCOME OF NON INVASIVE VENTILATION AND HIGH FLOW NASAL CANNULA THERAPY IN PATIENTS OF RESPIRATORY FAILURE IN TERTIARY CARE HOSPITAL – A PROSPECTIVE OBSERVATIONAL STUDY
30	2023	DR. PALLAVI JAYBHAYE	DR.GYANSHANKAR MISHRA	STUDY OF DIFFUSING CAPACITY OF THE LUNGS FOR CARBON MONOXIDE (DLCO) IN TREATED CASES OF MICROBIOLOGICALLY CONFIRMED DRUG RESISTANT PULMONARY TUBERCULOSIS: A CROSS-SECTIONAL STUDY
31	2023	DR. AYUSH BHUTADA	DR. RADHA MUNJE	IDENTIFYING ALLERGENS BY SKIN PRICK TESTING IN PATIENTS WITH RESPIRATORY ALLERGY AT A TERTIARY CARE CENTRE OF CENTRAL INDIA – A CROSS-SECTIONAL STUDY
32	2023	DR. NEHA JAIN	DR. RADHA MUNJE	“Gender based Clinicoradiological evaluation of chronic obstructive pulmonary disease-A cross sectional study”
33	2023	DR. MUKILAN VISHWANATHAN	DR. RADHA MUNJE	PREVALENCE OF LATENT TUBERCULOSIS INFECTION AMONG HOUSEHOLD CONTACTS OF MICROBIOLOGICALLY CONFIRMED PULMONARY TUBRECULOSIS OPD PATIENTS VS IN PATIENTS – A CASE CONTROL STUDY
34	2023	DR. AAKANSHA RATAN	DR. SANJAY GOUR	Assessment of sleep quality and obstructive sleep apnoea in patients of polycystic ovarian syndrome: A cross-sectional study.
35	2023	DR. VAIBHAV MANAPURE	DR. SANJAY GOUR	MICROBIOLOGICAL SPECTRUM AND DIAGNOSTIC YIELD IN BRONCHIECTASIS: A CROSS-SECTIONAL STUDY IN A TERTIARY CARE CENTRE
36	2023	DR. CHIDAMBARAM MANI	DR. SANJAY GOUR	A COMPARITIVE STUDY TO EVALUATE THE EFFICACY OF INTRAPLEURAL INSTILLATION OF 2-MERCAPTOPURINE SULFONATE SODIUM(MESNA) AND STREPTOKINASE IN TREATMENT OF MULTILOCULATED PLEURAL EFFUSION. A PROSPECTIVE, RANDOMISED CONTROLLED STUDY.
37	2023	DR. ATUL BORKAR	DR. GYANSHANKAR MISHRA	STUDY OF CLINICORADIOLOGICAL PRFILE OF UNACCOMPANIED PEOPLE DIAGNOSED WITH TB AND ADMITTED IN TERTIARY CARE CENTRE – A CASE CONTROL STUDY
38	2023	DR. ADITYA LOHIYA	DR. GYANSHANKAR MISHRA	A CROSS-SECTIONAL OBSERVATIONAL STUDY TO FIND OUT THE PREVALENCE OF TOBACCO ADDICTION IN COPD AND ITS ASSOCIATION WITH COMORBIDITIES IN COPD.
39	2024	Dr. Digambar Kanshette	DR. SANJAY GOUR	A comparative study of utility of FOT-IOS vs SPIROMETRY in early detection of small airway involvement in asymptomatic smokers
40	2024	Dr. Loretta Dsouza	DR. GYANSHANKAR MISHRA	Clinical Profile, Quality of Life and Economic Burden among Patients with Chronic Respiratory Disease on Long-Term Oxygen Therapy: A Cross-Sectional Study at a Tertiary Care Center
41	2024	Dr Ashfhan Shaikh	DR. RADHA MUNJE	Study on Utility of Forced Oscillation Technique (FOT) and Spirometry in assessing Pulmonary Function in Sickle Cell Disease Patients: A Comparative, prospective observational Study
42	2024	Dr. Vibhor Chandak	DR. RADHA MUNJE	PREVALENCE OF ASTHMA, ALLERGIC RHINOCONJUNCTIVITIS AND ECZEMA AMONG SCHOOL CHILDREN: A CROSS-SECTIONAL STUDY FROM NAGPUR CITY
43	2024	Dr. Vijaya Taksande	DR. GYANSHANKAR MISHRA	Hospitalization Outcomes in People With Pulmonary Tuberculosis in Tertiary Care: A Prospective Observational Cohort Study
44	2024	Dr. Manik Gongopale	DR. SANJAY GOUR	Fractional Exhaled Nitric Oxide (FENO) in Chronic Obstructive Pulmonary Patients : a prospective observational Study
45	2024	Dr. Poonam Limbikai	DR. RADHA MUNJE	Prospective observational study on the microbiological profile in hospitalised patients with suspected respiratory infections
46	2024	Dr. Nitesh Nakat	DR. SANJAY GOUR	Study of the Diffusing Capacity of Lungs for Carbon Monoxide in patients with Sickle Cell Trait (SCT) & Sickle Cell Disease (SCD) : a cross-sectional observational study